These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14584041)

  • 1. Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.
    Normanno N; De Luca A; Bianco C; Maiello MR; Carriero MV; Rehman A; Wechselberger C; Arra C; Strizzi L; Sanicola M; Salomon DS
    J Cell Physiol; 2004 Jan; 198(1):31-9. PubMed ID: 14584041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells.
    Fiucci G; Ravid D; Reich R; Liscovitch M
    Oncogene; 2002 Apr; 21(15):2365-75. PubMed ID: 11948420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
    Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ
    Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.
    Ravid D; Maor S; Werner H; Liscovitch M
    Oncogene; 2005 Feb; 24(8):1338-47. PubMed ID: 15592498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of human cripto-1 in tumor angiogenesis.
    Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
    J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
    Sivko GS; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
    Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation.
    Sabnis GJ; Jelovac D; Long B; Brodie A
    Cancer Res; 2005 May; 65(9):3903-10. PubMed ID: 15867390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.
    Schedin PJ; Eckel-Mahan KL; McDaniel SM; Prescott JD; Brodsky KS; Tentler JJ; Gutierrez-Hartmann A
    Oncogene; 2004 Mar; 23(9):1766-79. PubMed ID: 14767472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
    Emberley ED; Niu Y; Curtis L; Troup S; Mandal SK; Myers JN; Gibson SB; Murphy LC; Watson PH
    Cancer Res; 2005 Jul; 65(13):5696-702. PubMed ID: 15994944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
    Bianco C; Strizzi L; Rehman A; Normanno N; Wechselberger C; Sun Y; Khan N; Hirota M; Adkins H; Williams K; Margolis RU; Sanicola M; Salomon DS
    Cancer Res; 2003 Mar; 63(6):1192-7. PubMed ID: 12649175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells.
    Ebert AD; Wechselberger C; Frank S; Wallace-Jones B; Seno M; Martinez-Lacaci I; Bianco C; De Santis M; Weitzel HK; Salomon DS
    Cancer Res; 1999 Sep; 59(18):4502-5. PubMed ID: 10493495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
    Liu Y; Ludes-Meyers J; Zhang Y; Munoz-Medellin D; Kim HT; Lu C; Ge G; Schiff R; Hilsenbeck SG; Osborne CK; Brown PH
    Oncogene; 2002 Oct; 21(50):7680-9. PubMed ID: 12400010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells.
    Burdick AD; Davis JW; Liu KJ; Hudson LG; Shi H; Monske ML; Burchiel SW
    Cancer Res; 2003 Nov; 63(22):7825-33. PubMed ID: 14633709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.